Literature DB >> 24365018

AMH concentration is not related to effective time to pregnancy in women who conceive naturally.

Isabelle Streuli1, Jacques de Mouzon2, Céline Paccolat3, Charles Chapron4, Patrick Petignat3, Olivier P Irion3, Dominique de Ziegler2.   

Abstract

This study determined whether anti-Müllerian hormone (AMH) concentration influences the time necessary to conceive a live-born child--effective time to pregnancy (eTTP)--in a population of women who conceived naturally. This is an observational study of 87 women with a planned spontaneous pregnancy resulting in a live birth. eTTP was assessed retrospectively by a questionnaire and AMH was measured in a frozen serum sample from first trimester of pregnancy. eTTP was correlated with age (r=-0.24, P=0.02), but not with AMH (r=-0.10) or body mass index (r=0.05). With logistic regressions, the only variable that affected the probability of pregnancy within 3 or 6 months was age, irrespective of whether an AMH concentration limit of 1.0 ng/ml or 2.0 ng/ml was chosen. In conclusion, this study suggests that there is no relationship between AMH concentration and eTTP and therefore speaks against determining AMH in women who are not infertile for the purpose of predicting their chances of pregnancy. The findings are concordant with previous reports describing AMH as a quantitative but not a qualitative marker of ovarian reserve and therefore does not reflect a woman's ability to become pregnant. Anti-Müllerian hormone (AMH) is secreted by small growing ovarian follicles and reflects a woman's ovarian reserve - the number of primordial follicles at a given time. AMH concentrations has been extensively studied in infertile women but there are only scarce data on AMH in non-infertile women. Our objective was to determine whether AMH concentrations influence the time necessary to conceive a live-born child - also called effective time to pregnancy (eTTP) - in a population of women who conceived naturally. We conducted an observational study between 2007 and 2009 in which we assessed eTTP retrospectively in 87 women who had delivered a live-born child and measured AMH in a frozen blood sample collected during the first trimester of pregnancy. The results of our study show, as expected, a decrease of AMH concentrations as age increases but no relationship between AMH and eTTP. In conclusion, our study results suggest AMH concentrations do not influence the time necessary to conceive a live-born child spontaneously and therefore speak against determining AMH in women who are not infertile for the purpose of predicting their chances of pregnancy. Our findings are concordant with previous reports describing AMH as a quantitative but not a qualitative marker of ovarian function that does therefore not reflect a woman's ability to become pregnant.
Copyright © 2013 Reproductive Healthcare Ltd. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Müllerian-inhibiting substance; anti-Müllerian hormone; fecundity; natural conception; ovarian reserve; time to pregnancy

Mesh:

Substances:

Year:  2013        PMID: 24365018     DOI: 10.1016/j.rbmo.2013.10.007

Source DB:  PubMed          Journal:  Reprod Biomed Online        ISSN: 1472-6483            Impact factor:   3.828


  7 in total

1.  Chemotherapy-related damage to ovarian reserve in childhood cancer survivors: interpreting the evidence.

Authors:  Edgardo Somigliana; Monica Terenziani; Francesca Filippi; Alice Bergamini; Fabio Martinelli; Giorgia Mangili; Fedro Peccatori; Paolo Vercellini
Journal:  J Assist Reprod Genet       Date:  2018-10-25       Impact factor: 3.412

2.  Mitochondrial DNA copy number in peripheral blood: a potential non-invasive biomarker for female subfertility.

Authors:  Andrea Busnelli; Debora Lattuada; Raffaella Rossetti; Alessio Paffoni; Luca Persani; Luigi Fedele; Edgardo Somigliana
Journal:  J Assist Reprod Genet       Date:  2018-08-17       Impact factor: 3.412

3.  Is Anti-Müllerian Hormone Associated With Fecundability? Findings From the EAGeR Trial.

Authors:  Shvetha M Zarek; Emily M Mitchell; Lindsey A Sjaarda; Sunni L Mumford; Robert M Silver; Joseph B Stanford; Noya Galai; Mark V White; Karen C Schliep; Alan H DeCherney; Enrique F Schisterman
Journal:  J Clin Endocrinol Metab       Date:  2015-09-25       Impact factor: 5.958

4.  Back to the basics of ovarian aging: a population-based study on longitudinal anti-Müllerian hormone decline.

Authors:  A C de Kat; Y T van der Schouw; M J C Eijkemans; G C Herber-Gast; J A Visser; W M M Verschuren; F J M Broekmans
Journal:  BMC Med       Date:  2016-10-03       Impact factor: 8.775

5.  The likelihood of achieving pregnancy through timed coitus in young infertile women with decreased ovarian reserve.

Authors:  Hwa Seon Koo; In Ok Song; Sun Hwa Cha; Chan Woo Park; Hye Ok Kim
Journal:  Clin Exp Reprod Med       Date:  2018-03-30

6.  Anti-müllerian hormone levels are reduced in women living with human immunodeficiency virus compared to control women: a case-control study from Copenhagen, Denmark.

Authors:  Maria Wessman; Anne-Sofie Korsholm; Janne Gasseholm Bentzen; Anders Nyboe Andersen; Magnus Glindvad Ahlström; Terese Lea Katzenstein; Nina Weis
Journal:  J Virus Erad       Date:  2018-04-01

Review 7.  Maximizing the clinical utility of antimüllerian hormone testing in women's health.

Authors:  Benjamin Leader; Valerie L Baker
Journal:  Curr Opin Obstet Gynecol       Date:  2014-08       Impact factor: 1.927

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.